M-CRIT is taught by a multi-disciplinary team of distinguished University of Michigan Faculty working at the forefront of basic science, translational, and clinical cardiovascular research. Scroll down to learn about the Course Directors and Faculty.

Register Now

Course Directors

C. Alberto Figueroa, PhD

Edward B. Diethrich, M.D. Associate Professor of Biomedical Engineering and Vascular Surgery

After completing his BS and MS in Civil Engineering in Spain, Dr. Figueroa enrolled in a PhD program in Mechanical Engineering at Stanford University, where he developed computational methods to simulate blood flow within elastic models of arteries built from patient-specific medical images such as MRI and CT. He then worked as a Research Scientist in the Department of Bioengineering at Stanford, collaborating with the Vascular Surgery team. Learn more.

Daniel D. Myers, Jr., DVM, MPH, DACLAM

Professor of Vascular Surgery, Director, Conrad Jobst Vascular Research Laboratories

Dr. Myers received his DVM degree from Tuskegee University School of Veterinary Medicine, and completed his comparative medicine training at the University of Michigan. Dr. Myers received his Masters of Public Health in Hospital and Molecular Epidemiology from the University of Michigan. Currently Dr. Myers is Director of the Conrad Jobst Vascular Research Laboratories, University of Michigan and is nationally recognized for his expertise in translational animal model development. Learn more.

Course Faculty

Jonathan L. Eliason, MD

S. Martin Lindenauer Collegiate Associate Professor of Vascular Surgery, Medical Director, Diagnostic Vascular Labs

Dr. Eliason received his undergraduate degree from Bethel College in St. Paul, Minnesota and his medical degree from the University of Minnesota Medical School. He then relocated to Nashville, Tennessee where he completed his General Surgery Residency at Vanderbilt University Medical Center. Dr. Eliason became Chief Resident and proceeded into the two-year Vascular Surgery Fellowship at the University of Michigan. Learn more.

Lola Eniola-Adefeso, PhD

Professor of Chemical Engineering

Dr. Eniola-Adefeso is the director of the Cell Adhesion and Drug Delivery lab at the University of Michigan. She graduated from the University of Maryland Baltimore County (UMBC) with a bachelor’s in Chemical and Biomolecular Engineering. She completed her masters and doctoral degree in Chemical and Biomolecular Engineering at the University of Pennsylvania. She was postdoctoral associate at Baylor College of Medicine in Houston, Texas in the Pediatrics/Leukocyte Biology Department. Learn more.

Joan Greve, PhD

Assistant Professor of Biomedical Engineering

Joan is an MRI physiologist focused on preclinical models in an effort to improve the human condition. She received her BS (U. of Washington) and PhD (Stanford) in bioengineering. She has used MRI to develop the first application of phase-contrast MRI and computational fluid dynamic modeling in rodent models to examine how wall shear stress scales across species, as well as to study peripheral artery disease, vascular endothelial growth factor, and the relationship between angiogenesis and arteriogenesis. Joan has extensive regularity science knowledge, including co-authoring an IND application to the FDA and leading the imaging biomarker strategy for Phase I and II clinical trials. Learn more.

Elizabeth A. Jackson, MD

Associate Professor of Internal Medicine. Director, Women’s Heart Program

Dr. Elizabeth Jackson is an Assistant Professor of Medicine at the University of Michigan Health Center. Dr. Jackson graduated from Tufts University School of Medicine. After completing her internal medicine residency at Brown University’s Rhode Island Hospital, she completed a fellowship in cardiovascular medicine at New England Medical Center in Boston, Massachusetts and a research fellowship in preventive medicine at Brigham and Women’s Hospital in Boston, Massachusetts. Learn more.

Jose Jalife, MD

Cyrus and Jane Farrehi Professor of Cardiovascular Research, Professor of Internal Medicine and Molecular and Integrative Physiology, Co-director of the U-M Center for Arrhythmia Research

Dr. Jalife’s lab conducts research on the mechanisms of life-threatening cardiac arrhythmias. Their contributions have increased the understanding of atrial fibrillation (AF), which is the most important cause of stroke, and ventricular fibrillation (VF), which is the major cause of sudden cardiac death. They have demonstrated the role of rotors and of potassium channels in the mechanisms underlying AF and VF. They also contributed to the discovery of the genetic, molecular and electrophysiological bases the short QT syndrome type 3, and the arrhythmogenic mechanisms of catecholaminergic polymorphic ventricular tachycardia (CPVT). Learn more.

Minhaj S. Khaja, MD, MBA

Assistant Professor of Radiology in Vascular & Interventional Radiology (IR), Associate Program Director of the Diagnostic Radiology Residency, and Program Director of the IR Residency

Dr. Khaja completed his residency and fellowship training in the VIR Clinic Training Pathway at the University of Virginia, where he served as Chief fellow. At UVA, he was actively involved in the care of vascular patients in a collaborative environment. He completed a five-year MD/MBA joint degree program at the Indiana University School of Medicine and the Indiana University Kelley School of Business. Learn more.

Howard R. Levin, MD

President and Chief Scientific Officer at Coridea, LLC

Dr. Levin started his career as an academic cardiologist and researcher and has worked extensively towards the integration of cardiac, respiratory and renal physiological principles into novel clinical treatments.

Dr. Levin, with Mark Gelfand, co-founded Coridea, an incubator/idea generator that translates ideas into novel therapeutic solutions for clinical practice. His inventions and co-inventions have successfully launched or their patents helped launch companies including Ardian, CHF Solutions, Respicardia, eValve, RenalGuard, Cibiem and Soffio Medical. These companies have returned over $1B to their investors. Learn more.

Peter X. Ma, PhD

Richard H. Kingery Endowed Collegiate Professor of Dentistry, Professor of Biological and Material Science, Professor of Macromolecular Science and Engineering, Professor of Material Science and Engineering, Professor of Biomedical Engineering

Dr. Peter X. Ma received his BS and MS degrees from Tsinghua University in Beijing China. He received his PhD from Rutgers University and did his post-doctoral research at MIT and Harvard Medical School. Currently, Dr. Ma is the Richard H. Kingery Endowed Collegiate Professor at the University of Michigan. As a tenured Full Professor, he has quadruple appointments in the Department of Biologic and Materials Sciences in the School of Dentistry, the Departments of Biomedical Engineering, Materials Science and Engineering, and the Macromolecular Science and Engineering in the College of Engineering. Learn more.

Francis D. Pagani, MD, PhD

Professor of Cardiac Surgery

Dr. Pagani is the Surgical Director of the University Michigan’s Heart Transplant Program and the Director for the Center for Circulatory Support. Dr. Pagani’s clinical expertise includes treatment of hypertrophic cardiomyopathies, valvular heart disease, heart transplantation and mechanical circulatory support. His translational research focuses on the use of mechanical circulatory support in the treatment of advanced heart disease and the use of stem cell transplantation for myocardial regeneration. Learn more.

David M. Williams, MD

Professor of Radiology

Dr. Williams received his MD from the University of Michigan, where he also completed his residency in Radiology and Diagnostic Radiology, and a fellowship in Cardiovascular & Interventional Radiology. He has vast experience in the angiographic evaluation and endovascular treatment of aortic dissection complicated by malperfusion or impending or ongoing rupture, and in aneurysm treatment with endografts. Learn more.

Zhen Xu, PhD

Associate Professor of Biomedical Engineering, Associate Professor of Pediatrics and Communicable Diseases

Dr. Xu’s early papers include the first publication on histotripsy demonstrating that cavitation can be initiated and maintained in a controlled fashion to create tissue fractionation. Since then she has continued investigating the mechanism behind histotripsy on how the cavitation cloud is initiated by a single micro-second duration ultrasound pulse and how the cavitation dynamics is changed by the ultrasound pulsing parameters. This body of work laid the foundation for the invention and development of the histotripsy technique. Learn more.